Newsletter
RC: CRAACO: The Future of Clinical Trials with Jennifer Byrne, CEO at Javara

Outcomes Rocket

RC: CRAACO: The Future of Clinical Trials with Jennifer Byrne, CEO at Javara

October 11, 2022

RC: CRAACO: The Future of Clinical Trials with Jennifer Byrne, CEO at Javara

Clinical Research is not an individual sport, it is a team sport in which one variable affects every outcome.

In this episode, Jennifer Byrne, CEO of Javara, talks about taking a different approach to clinical research, improving it, and changing the narrative it has been associated with so far. In their conversation, Jennifer speaks about what an IRO is and why this type of company is different from other pharmaceutical companies conducting research nowadays. She presents CRAACO as an approach to clinical research and its intentions by giving some examples of its application. She brings awareness to different issues that occur in clinical research, including mistrust, complexity in systems and protocols, transparency, and teamwork. For her, the future of clinical trials will be in patient-centricity, understanding centricity as including the patient as part of the team.

Tune in to this episode to learn the hard things about clinical research and how to manage them!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
How is Parkinson’s Disease Diagnosed? And How Is a Care Team Created? Parkinson’s disease can’t be diagnosed through a simple blood test or scan. After a referral from a primary care doctor, it often takes visits to a neurologist or movement disorder specialist before receiving a clinical diagnosis.